A series of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides bearing the halogens iodine and bromine were synthesised and their binding affinity for the peripheral benzodiazepine binding sites (PBBS) in rat kidney mitochondrial membranes were evaluated using [3H]-PK11195. Central benzodiazepine receptor (CBR) affinities were also evaluated in rat cortices using 3H-flumazenil to determine their selectivity for PBBS over CBR. The tested compounds had PBBS binding affinities (IC50) ranging from 7.86 nM to 618 nM, with all compounds showing high selectivity over the CBR (CBR IC50 > 5000 nM). Among the 12 compounds tested, those with a diethylamide group were the most potent. The highest affinity iodinated PBBS ligand, N,N-diethyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4c), was radiolabelled with iodine-123. This high affinity and selective radioligand may be useful for imaging neurodegeneration, inflammation and tumours using single photon emission computed tomography (SPECT). 
The development of specific radiotracers for the PBBS has not only contributed to the elucidation of the receptor's biochemical functions, but when imaged with positron emission tomography (PET) and single photon emission computed tomography (SPECT), provide a means by which these changes can be monitored and correlated to disease. 10, 11, 12, 13 
Figure 1. Structures of PBBS ligands
More recently, imidazopyridines 15 and pyridazines 16 and indoles such FGIN-1-27 17, 18 (Figure 1) have all been reported to bind to the PBBS. Several of these ligands have been radiolabelled with iodine-123, for potential imaging using SPECT. 16.19,20 N,N-Dialkyl-2-phenylindolyl-3-glyoxylamides ( Figure 2 ) represent a new class of potent PBBS ligands, whose development was based on conformationally constrained analogues of 2-phenylindole-3-acetamides. 21 These compounds offer the potential for radiolabelling with radionuclides for both PET and SPECT imaging. In this investigation we synthesised and tested several of halogenated derivatives of these systems with the aim of radiolabelling with iodine-123 for studying PBBS using SPECT. 
Chemistry
The N,N-dialkyl-2-phenylindol-3-ylglyoxylamides 4a-l were synthesised following literature methods 21 for similar compounds and is outlined in scheme 1. Briefly, 2-(4-bromophenyl)indole 2d
was synthesised in one step, from 4-bromoacetophenone and phenylhydrazine with polyphosphoric acid, 22 while indoles 2a-c were synthesised in two steps via their phenylhydrazone derivatives 1a-c. 23 The phenylhydrazones were formed by reacting 4-bromo or 4-iodo acetophenone with phenylhydrazine or 4-chlorophenylhydrazine hydrochloride, followed by cyclisation by the Fischer indole synthesis using polyphosphoric acid. Subsequent acylation using oxalyl chloride gave the indolylglyoxylyl chlorides 3a-d, which were aminated using the appropriate amines eg dihexylamine, di-n-propylamine, diethylamine, or dimethylamine giving the final N,N-dialkyl-2-phenylindolyl-3-glyoxamides 4a-l in good overall yields. for the PBBS and the CBR are shown in Table 1 . The compounds examined displayed a medium to high affinity for the PBBS, ranging from 7.86 nM to 618 nM. All compounds had high selectivity for PBBS over CBR, with all CBR IC 50 > 5000 nM. The effects of chemical modification to groups R 1 to R 4 on the binding to PBBS was studied, including the length of the alkyl chains (R 1 and R 2 ), the presence of a chloro substituent on position 5 of the indole (R 4 ), and halogen substitution (bromine or iodine) on the phenyl ring (R 3 ). The most potent ligands for the PBBS were compounds 4c and 4k, both displaying IC 50 of <10 nM. Decreasing the length of the alkyl chains from hexyl to propyl to ethyl, increased the binding affinity for the PBBS. However, compounds with R 1 and R 2 as methyl groups had a lower affinity than the compounds with ethyl groups. The compounds with a bromo substituent on R 3 , 4i-l, had higher PBBS affinities than their respective iodo analogues 4a-c, and 4e. This suggests that the smaller the halogen on R 3 , the better the binding affinity. Although no direct comparison can be made, compounds reported previously 21 with smaller halogen (fluorine and chlorine) substituents on R 3 appeared to have a higher PBBS binding affinity than compounds presented here. It was also reported 21 that the optimum alkyl chain length (R 1 and R 2 ) for compounds with no chloro substituent on R 4 were hexyl groups, whereas with the chloro substituent, the optimum length was propyl. In this work it was found that compounds with hexyl groups had the lowest affinities, with and without a chloro substituent. It was also found that affinities increased with the addition of a chloro substituent in compounds containing propyl, ethyl or methyl groups. 21 Compounds 4e and 4l containing hexyl groups showed higher PBBS affinity than compounds 4a and 4i with a chloro group in the R 4 . This suggests that it is more difficult to accommodate the sterically more demanding hexyl groups on molecules with R 4 = Cl than in compounds with R 4 = H, suggesting different molecular orientations are possible. Lipophilicity measurements of all compounds were assessed in order to explain their in vivo properties. As expected the presence of bulky alkyl groups (R 1 and R 2 ) greatly influenced the overall lipophilicity of the molecules resulting in compounds 4a, 4e, 4i, and 4l having log P values greater than 6 and molecules with propyl groups 4b, 4f, 4j greater than 4. In addition, incorporating a chloro substituent on R 4 increased the log P values from 3.27 in 4g and 2.69 in 4h to 4.0 in 4c and 3.36 in 4d respectively. However, the presence of small alkyl groups such as ethyl and methyl in the R 1 and R 2 positions and hydrogen in the R 4 positions can yield compounds with log P values between 2 and 4. radiochemical purity.
Conclusion

Experimental
Melting points were determined on a Gallenkamp melting point apparatus and were uncorrected. and multiplet (m). Mass spectra (MS) were obtained using either a VG Quattro triple quadrupole system or an Autospec high-resolution mass spectrometer. Analytical thin layer chromatography (TLC) was performed on Merck Kieselgel 60 F 254 precoated polyester plates with a thickness of 250 μm. Column chromatography was performed on Merck Keiselgel 60 (220-440 mesh). Reagents and solvents were purchased from commercial sources and were used without further purification.
Petroleum ether of boiling point range 30-60 °C was used. Yields refer to purified products and are not optimised. Chromatographic separation of radiolabelled product was carried out on a
Phenomenex bondclone semi-preparative RP C-18 column (10 μ, 7.8 mm x 300 mm) using a Waters 510 pump, an Activon Linear UV detector set at 254 nm, and an in-line NaI-Berthold radioactivity detector. Carrier free Na 123 I in 0.1M NaOH was obtained from Australian Radioisotopes and Industrials (ARI), Australia. Sprague Dawley rats were purchased from Animal Resources Centre (Perth, WA, Australia). All procedures were carried out in compliance with Australian laws governing animal experimentation.
4-Iodoacetophenone 4-chlorophenylhydrazone (1a)
A 
4-Iodoacetophenone phenylhydrazone (1b)
In similar manner, 4-iodoacetophenone (5.00 g, 20.3 mmol) and phenylhydrazine (2.0 mL, 20.3 mmol) in ethanol (30 mL) gave 1b (4.38 g, 64%) as orange crystals. 
4-Bromoacetophenone 4-chlorophenylhydrazone (1c)
In a similar manner, 4-bromoacetophenone (6.89 g, 34.6 mmol) and 4-chlorophenylhydrazine 
5-Chloro-2-(4-iodophenyl)indole (2a)
A mixture of 1a (3.10 g, 8.4 mmol) and polyphosphoric acid (20 g) was stirred for 30 min at 110 °C. Ice water (250 mL) was added and the mixture was stirred. 
2-(4-Bromophenyl)indole (2d) 22
To a mixture of 4-bromoacetophenone (6.89 g, 34.6 mmol) and phenylhydrazine (3.4 mL, 34.6 mmol) was added polyphosphoric acid (40 g). The reaction mixture was heated at 110 °C, stirring occasionally until the mixture turned a deep reddish brown colour. The reaction mixture was worked up the same as 2a to yield 2d (5.41 g, 58%) as a white solid. 
[5-Chloro-2-(4-iodophenyl)indol-3-yl]glyoxylyl chloride (3a)
To a partially dissolved solution of indole 2a (0.65 g, 1.84 mmol) in anhydrous diethyl ether at 0 °C, was added dropwise oxalyl chloride (0.22 mL, 2.57 mmol) and the mixture stirred for 6 h at room temperature. The precipitate was collected by filtration and washed with a small portion of diethyl ether to yield 3a (0.72 g, 88%) which was directly used to synthesise 4a-d.
(DMSO- 
[2-(4-Bromophenyl)indol-3yl]glyoxylyl chloride (3d)
Reaction of 2d (2.00 g, 7.35 mmol) and oxalyl chloride (0.90 mL, 10.3 mmol) in diethyl ether (20 mL) for 1 h gave 3d (1.75 g, 66%). 
N,N-Dihexyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4a)
To a solution of the chloride 3a (0.30 g, 0.67 mmol) and triethylamine (0.11 mL, 0.81 mmol) in anhydrous toluene (30 mL) at 0 °C was added dropwise a solution of dihexylamine (0.17 mL, 0.74 mmol) in anhydrous toluene (20 mL 
N,N-Di-n-propyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4b)
Reaction of 3a (0.72 g, 1.62 mmol) and di-n-propylamine (0.25 mL, 1.78 mmol) for 7 h as above gave after trituration with petroleum ether, 4b (0.47 g, 57%) as an off-white solid: mp 148-150 °C. 
N,N-Diethyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4c)
Reaction of 3a (0.36 g, 0.80 mmol) and diethylamine (0. 
N,N-Dimethyl-[5-chloro-2-(4-iodophenyl)indol-3-yl]glyoxylamide (4d)
Dimethylamine (30 mL, 40% wt/vol in water) was gently heated and under constant N 2 pressure bubbled through NaOH pellets into a solution of 3a (0. 
N,N-Dihexyl-2-(4-iodophenyl)indol-3-ylglyoxylamide (4e)
N,N-Diethyl-[2-(4-iodophenyl)indol-3-yl]glyoxylamide (4g)
Reaction of 3b (0.14 g, 0.34 mmol) and diethylamine (0.05 mL, 0.47 mmol) for 3 h gave after Found: C, 53.50; H, 4.41; N, 6.11.
N,N-Dimethyl-[2-(4-iodophenyl)indol-3-yl]glyoxylamide (4h)
Dimethylamine (30 mL, 40% wt/vol in water) was gently heated and under constant N 2 pressure bubbled through NaOH pellets into a solution of 3b (0.30 g, 0.73 mmol) in toluene. After column chromatography (ethyl acetate/ petroleum ether, 1:1 v/v), 4h was obtained (14 mg, 5%) as an off- 
N,N-Di-n-propyl-[2-(4-bromophenyl)-5-chloroindol-3-ylglyoxylamide (4j)
Reaction of 3c (0.41 g, 1.03 mmol) and di-n-propylamine (0. 
N,N-Diethyl-[2-(4-bromophenyl)-5-chloroindol-3-ylglyoxylamide (4k)
To a solution 3c (0.72 g, 1.81 mmol) in anhydrous toluene (40 mL) at 0 °C was added dropwise a solution of triethylamine (0.30 mL, 2.18 mmol) and diethylamine (0.21 mL, 1.99 mmol) in anhydrous toluene (10 mL injected onto a semi-preparative C-18 RP HPLC column. The retention time at a flow rate of 3 mL/min was 16 min. The radiochemical purity was > 96% after formulation in saline.
Lipophilicity Measurements
Samples were analysed using a C18 column (X-Terra, 5μ, 4.6 x 250 mm) and a mobile phase of methanol and 0.1M phosphate buffer (65:35 v/v, pH = 7.5) with a flow rate of 1 mL/min. 24 The log P values were estimated by comparing HPLC retention times (RT) of test compounds with retention times of standards having known log P values. The standards used were aniline, benzene, bromobenzene, ethylbenzene and trimethylbenzene. A calibration curve of log P vs. ln RT was generated. The equation was linear with an r 2 of 0.9969. Calculated log P values were found using Chem Draw Ultra. of ice-cold buffer, the preparation was homogenised and the suspension was centrifuged at 49,000 g for 15 min at 4 °C. The pellets were resuspended in buffer to achieve a protein concentration of 4 mg/mL. Membranes were stored at -80 o C until required. 25, 26 Protein content in the membrane suspensions was measured according to a colorimetric method. 27 For determination of the inhibition constant (IC 50 ), assays were run in triplicate with concentrations of test compounds ranging from 
In vitro
